Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pattern of sumatriptan use and overuse in general practice

J P Ottervanger1, H A Valkenburg, D E Grobbee

  • 1Netherlands Centre for Monitoring of Adverse Reactions to Drugs, Rijswijk, The Netherlands.

European Journal of Clinical Pharmacology
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are higher antidepressant plasma concentrations associated with fall risk in older antidepressant users?

European geriatric medicine·2023
Same author

Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortium.

PloS one·2022
Same author

Candidate genetic variants and antidepressant-related fall risk in middle-aged and older adults.

PloS one·2022
Same author

Appendectomy and the subsequent risk of cancer: A prospective population-based cohort study with long follow-up.

Cancer epidemiology·2022
Same author

A Propensity Score Matched Approach to Assess the Associations of Commonly Prescribed Medications with Fall Risk in a Large Harmonized Cohort of Older Ambulatory Persons.

Drugs & aging·2021
Same author

Prevalence of and risk factors for extended-spectrum beta-lactamase genes carriership in a population-based cohort of middle-aged and elderly.

International journal of antimicrobial agents·2021

A small group of sumatriptan (sumatriptan) users, approximately 4%, were identified as overusers. Overuse was linked to male gender and perceived low sumatriptan efficacy, not age.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Epidemiology

Background:

  • Sumatriptan is a common medication for acute migraine attacks.
  • Understanding patterns of sumatriptan use and misuse is crucial for patient safety and treatment efficacy.
  • Identifying characteristics of patients who overuse sumatriptan can inform targeted interventions.

Purpose of the Study:

  • To determine the frequency of sumatriptan use and overuse among patients.
  • To characterize patients who report overuse of sumatriptan.
  • To investigate factors associated with sumatriptan overuse.

Main Methods:

  • A postmarketing cohort study was conducted in the Netherlands.
  • Data were collected via questionnaires sent to patients prescribed sumatriptan by general practitioners.

Related Experiment Videos

  • Sumatriptan intake was categorized, with daily use exceeding 10 times per week defined as overuse.

    • Main Results:

    • A response rate of 70% was achieved from 1720 patients.
    • Details on sumatriptan intake were available for 952 patients.
    • 4% of patients (36 individuals) were classified as overusers, taking sumatriptan daily or more than 10 times weekly. Overusers were predominantly male and reported poor sumatriptan efficacy.

    Conclusions:

    • A small but significant proportion of patients overuse sumatriptan.
    • Male gender and perceived low efficacy are associated with sumatriptan overuse.
    • Healthcare providers should educate patients on appropriate sumatriptan use and monitor consumption patterns, especially in those reporting low efficacy.